Companies / United States
FTC Probes Authorised Generics
April 2006 | Company Finance AlertThe US Federal Trade Commission (FTC) has started a 2-month investigation into the competitive effects of authorised generics in the prescription drug market. At total of 190 companies - including 80 brand name pharmaceutical firms, 10 authorised generic companies and 100 independent generic manufacturers - will be subpoenaed to provide information to the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
